The CEO of SpineFrontier, Inc. has pleaded guilty to making false statements to the Centers for Medicare & Medicaid Services. Dr. Kingsley R. Chin, the Founder, President and CEO of SpineFrontier, Inc., a Massachusetts-based medical device company, pleaded guilty on May 15, 2025, to one count of false statements to the Centers for Medicare & Medicaid Services’ (CMS) Open Payments Program. Pursuant to the Physician Payment Sunshine Act, device manufacturers, like SpineFrontier, are required to report any payments or transfers of value to physicians, including spine surgeons. CMS maintains a database, via the Open Payments website, which makes all such payments or transfers of value publicly accessible.
According to the charging documents, SpineFrontier offered surgeons the opportunity to engage in purported consulting on product development. Specifically, Chin directed his employees to report the payment of fees paid to a surgeon as consulting fees that were not compensation for actual consulting work. Chin caused his employees to report a payment of $4,750 on Jan. 19, 2016, to the surgeon as a “consulting” payment, even though Chin knew that the surgeon had not performed actual consulting work for the payment. He also knew that he and SpineFrontier were required to accurately report any payments or transfers of value to the surgeon.